AC Immune (ACIU) Real Estate - Net (2017 - 2025)
AC Immune (ACIU) posted quarterly Real Estate - Net of -$212698.9 for Q4 2025, down 245.05% year-over-year from $146634.2 in Q4 2024, and little changed quarter-over-quarter from -$212518.6 in Q3 2025.
Powered by 
Analysis
AC Immune (ACIU) Real Estate - Net (2017 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Real Estate - Net for 6 consecutive years, with -$212698.9 the latest figure, recorded in Q4 2025.
- In Q4 2025, Real Estate - Net fell 245.05% year-over-year to -$212698.9; the TTM figure through Dec 2025 stood at -$212698.9 (down 245.05% YoY), while the FY2025 annual figure was -$205041.8, down 232.63% from the prior year.
- Real Estate - Net held at -$212698.9 in Q4 2025 per ACIU's latest filing, from -$212518.6 in the prior quarter.
- Across five years, Real Estate - Net topped out at $2076.6 in Q2 2022 and bottomed at -$212698.9 in Q4 2025.
- Historically, Real Estate - Net has averaged -$88913.9 across 4 years, with a median of -$61642.2 in 2024.
- Annual changes were most pronounced in 2022 — Real Estate - Net soared 106.56% — and 2025, when it tumbled 245.05%.
- AC Immune's Real Estate - Net stood at -$31450.6 in 2021, then soared by 106.58% to $2070.9 in 2022, then tumbled by 3076.57% to -$61642.2 in 2024, then sank by 245.05% to -$212698.9 in 2025.
- Business Quant data shows ACIU's Real Estate - Net at -$212698.9 in Q4 2025, -$212518.6 in Q3 2025, and -$205341.3 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -212,698.86 |
| Sep 30, 2025 | -212,518.62 |
| Jun 30, 2025 | -205,341.34 |
| Mar 31, 2025 | -189,082.59 |
| Dec 31, 2024 | -61,642.18 |
| Sep 30, 2024 | -62,327.19 |
| Jun 30, 2024 | -59,712.85 |
| Mar 31, 2024 | -61,866.84 |
| Dec 31, 2022 | 2,076.04 |
| Sep 30, 2022 | 2,070.91 |
| Jun 30, 2022 | 2,076.59 |
| Dec 31, 2021 | -31,450.56 |
| Sep 30, 2021 | -31,584.74 |
| Jun 30, 2021 | -31,802.77 |
| Dec 31, 2020 | -32,078.51 |
| Dec 31, 2018 | -178.86 Mn |
| Mar 31, 2018 | -88,570.12 |
| Dec 31, 2017 | -40.54 Mn |